Candidemia: An Update on Epidemiology, Risk Factors, Diagnosis, Susceptibility, and Treatment
Pathogens · 14.08.2025 · 14 (8) · 806
DOI: 10.3390/pathogens14080806 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathogens, online erschienen am 14.08.2025. Verfasst von Juan Pablo Cabrera-Guerrero und 7 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Microbiología, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas (INER), Calz. de Tlalpan 4502, Belisario Domínguez …. Hauptthemen laut MEDLINE: Candidemia, Antifungal Agents, Candida. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 190 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Candidemia is a highly prevalent invasive fungal infection caused primarily by C. albicans, C. parapsilosis, C. glabrata (currently Nakaseomyces glabratus), C. tropicalis, and C. krusei (currently Pichia kudriavzevii). Risk factors for the development of candidemia include steroid-induced immunosuppression used in solid organ or hematopoietic transplantation, and neutropenia secondary to infectious or tumorous processes. Alterations in the gut microbiota in people living with HIV, caused by antiretroviral therapy, increase the possibility of colonization by C. albicans. Likewise, the presence of a central venous catheter, parenteral nutrition, and abdominal surgery stand out as the main risk factors for the development of candidemia. New diagnostic tools have been developed for the diagnosis of this mycosis that allow the identification of the main species, from improvements in conventional stains such as calcofluor white, which increases sensitivity, as well as technologies such as T2 Candida, MoiM assay, biomarker panel (1,3 β-D-glucan, C-reactive protein, presepsin, and procalcitonin), and, more recently, the development of biosensors for the identification of Candida spp. Regarding treatment, the use of micafungin and anidulafungin in patients with obesity defined by a BMI > 30 kg/m2 has shown higher survival rates and therapeutic success. Meanwhile, newer antifungals such as rezafungin and fosmanogepix have demonstrated excellent results in the treatment of these patients. Therefore, this review aims to update the epidemiology and risk factors of candidemia, as well as analyze the diagnostic tools and treatments currently available.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Servicio de Microbiología, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas (INER), Calz. de Tlalpan 4502, Belisario Domínguez Secc 16, Tlalpan, Mexico City 14080, Mexico.
- Servicio de Infectología, Hospital Regional de Alta Especialidad de Ixtapaluca (HRAEI), Servicios de Salud del Instituto Mexicano de Seguro Social para el Bienestar (IMSS-BIENESTAR), Carretera Federal México-Puebla Km 3…
- Laboratorio de Micología Molecular, Unidad de Investigación Biomédica, Hospital Regional de Alta Especialidad de Ixtapaluca (HRAEI), Servicios de Salud del Instituto Mexicano de Seguro Social para el Bienestar (IMSS-BIE…
- Servicio de Infectología, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas (INER), Calz. de Tlalpan 4502, Belisario Domínguez Secc 16, Tlalpan, Mexico City 14080, Mexico.
- Centro Nacional de Prevención y Control de Enfermedades (CENAPRECE), Francisco de P. Miranda No. 157, Col. Unidad Lomas de Plateros, Álvaro Obregón, Mexico City 01480, Mexico.
- Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Plan de San Luis y Díaz Mirón, Mexico City 11340, Mexico.
ORCID-Profile: Alberto Chinney Herrera, Erick Martínez-Herrera, Rodolfo Pinto-Almazán, María Guadalupe Frías-De-León, Carlos Alberto Castro-Fuentes
Zitieren
APA
Cabrera-Guerrero, J. P., García-Salazar, E., Hernandez Silva, G., Chinney Herrera, A., Martínez-Herrera, E., Pinto-Almazán, R., Frías-De-León, M. G., & Castro-Fuentes, C. A. (2025). Candidemia: An Update on Epidemiology, Risk Factors, Diagnosis, Susceptibility, and Treatment. Pathogens, 14(8), 806. https://doi.org/10.3390/pathogens14080806
Vancouver
Cabrera-Guerrero JP, García-Salazar E, Hernandez Silva G, Chinney Herrera A, Martínez-Herrera E, Pinto-Almazán R, et al. Candidemia: An Update on Epidemiology, Risk Factors, Diagnosis, Susceptibility, and Treatment. Pathogens. 2025;14(8):806. doi:10.3390/pathogens14080806
BibTeX
@article{CabreraGuerrero2025,
author = {Cabrera-Guerrero, Juan Pablo and García-Salazar, Eduardo and Hernandez Silva, Graciela and Chinney Herrera, Alberto and Martínez-Herrera, Erick and Pinto-Almazán, Rodolfo and Frías-De-León, María Guadalupe and Castro-Fuentes, Carlos Alberto},
title = {Candidemia: An Update on Epidemiology, Risk Factors, Diagnosis, Susceptibility, and Treatment},
journal = {Pathogens},
year = {2025},
volume = {14},
number = {8},
pages = {806},
doi = {10.3390/pathogens14080806}
}
EUVIMED